TagPharmaceutical Benefits Scheme (PBS)

Utilisation of pre-exposure prophylaxis (PrEP) for HIV prevention in the Australian general practice setting

U

Chidwick Kendal, Pollack Allan, Busingye Doreen, Norman Sarah, Grulich Andrew, Bavinton Benjamin, Guy Rebecca, Medland Nick (2022) Utilisation of pre-exposure prophylaxis (PrEP) for HIV prevention in the Australian general practice setting: a longitudinal observational study. Sexual Health 19, 101-111. Abstract: Background: Pre-exposure prophylaxis (PrEP) became available through the Australian...

What makes gay and bisexual men in Australia choose not to take PrEP?

W

nam/aidsmap, 14 April 2022 Perceived irrelevance, lack of awareness, problems with access, side effects, negative social impacts, and concerns about lack of STI protection, effectiveness and adherence are the most common reasons for not using PrEP among gay and bisexual men in Australia. This is according to a study recently published in the journal Behavioral Medicine which analysed reasons for...

Continuing declines in HIV diagnoses thanks to successful PrEP rollout in NSW

C

 Kirby Institute at UNSW, Friday July 2nd, 2021 New research from the Kirby Institute at UNSW Sydney shows that HIV transmissions are at historically low rates among almost 10,000 high-risk gay and bisexual men on pre-exposure prophylaxis (PrEP), the HIV prevention medication. Low HIV rates persisted after PrEP moved from being available cost-free as part of a NSW clinical trial, to being...

Agenda 2025: Ending HIV transmission in Australia in four years

A

Australian Federation of AIDS Organisations (AFAO), 17th June 2021 Agenda 2025 is a fully costed plan which draws upon evidence based research and is backed by top researchers, leaders, and clinicians in Australia’s community-led HIV response.  Australia can end HIV transmission within four short years, averting over 6,000 infections by 2030 and saving $1.4 billion in health costs, according to a...

Changes in use of hormonal long‐acting reversible contraceptive methods in Australia 2006 – 2018

C

Changes in use of hormonal long‐acting reversible contraceptive methods in Australia between 2006 and 2018: A population‐based study Luke E. Grzeskowiak,  Helen Calabretto, Natalie Amos, Danielle Mazza, Jenni Ilomaki ANZJOG First published: 23 October 2020,  Abstract: Background Long‐acting reversible contraceptives (LARCs) are promoted internationally as a key strategy for reducing unintended...

Shortage of norethisterone-containing pills in Australia: Advice for GPs

S

July/August 2020 The Therapeutic Goods Administration (TGA) advises: Consumers and health professionals are advised that there is a shortage of oral contraceptive pills containing the combination ethinylestradiol and norethisterone. The affected products are: Brevinor – norethisterone 0.5 mg and ethinylestradiol 35 micrograms Norimin – norethisterone 0.5 mg and ethinylestradiol 35...

Welcome to SASHA

SASHA is a current awareness service with news and views on various aspects of sexual health and sexuality, from a wide range of sources. These range from credible sources of sexual health and related information, to relevant opinion pieces in the media.

Categories